A groundbreaking study reveals a potential game-changer for newborn survival in Tanzania and beyond. The power of portable fetal heart monitoring could be the key to reducing newborn deaths, especially in low-resource settings. But here's where it gets controversial: is this technology a luxury, or a necessity for every pregnant woman, regardless of her circumstances?**
In a world where 99% of global newborn deaths occur in low- and middle-income countries (LMICs), access to adequate fetal monitoring is a critical challenge. Tanzania, with its high neonatal death rate, is a prime example. However, a new wireless technology is offering hope.
Researchers from Hiroshima University and Muhimbili University of Health and Allied Sciences in Tanzania have evaluated a mobile cardiotocography device (iCTG) for fetal heart rate monitoring. The results, published in BMC Public Health, are nothing short of remarkable. The device increased the detection of abnormal fetal heart rates by a staggering 8-10 times, and the risk of stillbirths and neonatal deaths was reduced by more than half.
Professor Yoko Shimpuku, corresponding author of the study, emphasizes, "iCTG is not a luxury technology; it's a practical, lifesaving tool." This wireless device acts as a lifeline, notifying healthcare providers of any abnormalities, allowing for timely interventions.
The main causes of stillbirths and neonatal deaths in Tanzania are prematurity and hypoxia. Traditional fetal monitoring methods in LMICs are often immobile and expensive to maintain, or limited to basic tools like fetoscopes, which can miss crucial signs of fetal distress. iCTG, on the other hand, is smart, wireless, and user-friendly, providing a more sensitive and accurate monitoring system.
During the study period, from October 2023 to September 2024, researchers enrolled 763 women at 32 weeks gestation or later across four facilities. The results speak for themselves: perinatal mortality dropped significantly to 2.6% for the iCTG group, compared to 6.6% for those without the device. The device's sensitivity was also exceptional, detecting fetal heart rate abnormalities 8-10 times more frequently than standard techniques.
However, the use of iCTG also led to higher rates of caesarean sections (27.6% vs. 10.3%). While surgical delivery can be life-saving, the researchers stress the need for clear clinical guidelines to prevent unnecessary procedures. This highlights the importance of combining technology with proper medical protocols.
Expanding access to iCTG is crucial. Attendance at antenatal clinics (ANCs) can be low in LMICs due to various barriers. Previous research suggests that women with iCTG access are more likely to attend ANCs, but this study found the opposite. The researchers believe this is due to the late introduction of the intervention and suggest using iCTG earlier in pregnancy to encourage attendance and combine it with health education efforts.
The researchers emphasize that heart rate monitoring technology should be integrated with other aspects of high-quality care for the best outcomes. They plan to expand iCTG use to larger, more diverse settings while evaluating its cost-effectiveness and long-term impact. Professor Shimpuku concludes, "Our goal is to ensure every pregnant woman, no matter where she lives, has access to accurate fetal monitoring and safer childbirth."
This study, funded by the Japan Agency for Medical Research and Development and developed by Melody International Ltd., is a step towards achieving that goal. It showcases the potential of innovative technology to bridge the gap in healthcare and save lives.
